173 related articles for article (PubMed ID: 24700876)
41. Pannexin-1 mediates fluid shear stress-sensitive purinergic signaling and cyst growth in polycystic kidney disease.
Verschuren EHJ; Rigalli JP; Castenmiller C; Rohrbach MU; Bindels RJM; Peters DJM; Arjona FJ; Hoenderop JGJ
FASEB J; 2020 May; 34(5):6382-6398. PubMed ID: 32159259
[TBL] [Abstract][Full Text] [Related]
42. The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity.
Tran U; Zakin L; Schweickert A; Agrawal R; Döger R; Blum M; De Robertis EM; Wessely O
Development; 2010 Apr; 137(7):1107-16. PubMed ID: 20215348
[TBL] [Abstract][Full Text] [Related]
43. Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease.
Wang X; Jiang L; Thao K; Sussman CR; LaBranche T; Palmer M; Harris PC; McKnight GS; Hoeflich KP; Schalm S; Torres VE
J Am Soc Nephrol; 2022 Jun; 33(6):1087-1104. PubMed ID: 35236775
[TBL] [Abstract][Full Text] [Related]
44. Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival.
Nagel DJ; Aizawa T; Jeon KI; Liu W; Mohan A; Wei H; Miano JM; Florio VA; Gao P; Korshunov VA; Berk BC; Yan C
Circ Res; 2006 Mar; 98(6):777-84. PubMed ID: 16514069
[TBL] [Abstract][Full Text] [Related]
45. Seihai-to (TJ-90)-Induced Activation of Airway Ciliary Beatings of Mice: Ca
Kogiso H; Ikeuchi Y; Sumiya M; Hosogi S; Tanaka S; Shimamoto C; Inui T; Marunaka Y; Nakahari T
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495403
[TBL] [Abstract][Full Text] [Related]
46. Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) splice variants from bovine cardiac muscle.
Das SB; Dinh C; Shah S; Olson D; Ross A; Selvakumar P; Sharma RK
Gene; 2007 Jul; 396(2):283-92. PubMed ID: 17467927
[TBL] [Abstract][Full Text] [Related]
47. MiR-541-5p regulates lung fibrosis by targeting cyclic nucleotide phosphodiesterase 1A.
Ren L; Yang C; Dou Y; Zhan R; Sun Y; Yu Y
Exp Lung Res; 2017; 43(6-7):249-258. PubMed ID: 28816543
[TBL] [Abstract][Full Text] [Related]
48. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1.
Abusnina A; Keravis T; Yougbaré I; Bronner C; Lugnier C
Mol Nutr Food Res; 2011 Nov; 55(11):1677-89. PubMed ID: 22045655
[TBL] [Abstract][Full Text] [Related]
49. Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells.
Sutters M; Yamaguchi T; Maser RL; Magenheimer BS; St John PL; Abrahamson DR; Grantham JJ; Calvet JP
Kidney Int; 2001 Aug; 60(2):484-94. PubMed ID: 11473631
[TBL] [Abstract][Full Text] [Related]
50. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models.
Cao Y; Semanchik N; Lee SH; Somlo S; Barbano PE; Coifman R; Sun Z
Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21819-24. PubMed ID: 19966229
[TBL] [Abstract][Full Text] [Related]
51. Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells.
Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Zhou W; Grande JP
Exp Biol Med (Maywood); 2006 Mar; 231(3):288-95. PubMed ID: 16514175
[TBL] [Abstract][Full Text] [Related]
52. Glycogen synthase kinase-3β promotes cyst expansion in polycystic kidney disease.
Tao S; Kakade VR; Woodgett JR; Pandey P; Suderman ED; Rajagopal M; Rao R
Kidney Int; 2015 Jun; 87(6):1164-75. PubMed ID: 25629553
[TBL] [Abstract][Full Text] [Related]
53. Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease.
Sun Y; Liu Z; Cao X; Lu Y; Mi Z; He C; Liu J; Zheng Z; Li MJ; Li T; Xu D; Wu M; Cao Y; Li Y; Yang B; Mei C; Zhang L; Chen Y
Sci Adv; 2019 Jun; 5(6):eaaw3593. PubMed ID: 31183407
[TBL] [Abstract][Full Text] [Related]
54. Phosphodiesterase 1C integrates store-operated calcium entry and cAMP signaling in leading-edge protrusions of migrating human arterial myocytes.
Brzezinska P; Simpson NJ; Hubert F; Jacobs AN; Umana MB; MacKeil JL; Burke-Kleinman J; Payne DM; Ferguson AV; Maurice DH
J Biol Chem; 2021; 296():100606. PubMed ID: 33789162
[TBL] [Abstract][Full Text] [Related]
55. Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype.
Yamaguchi T; Wallace DP; Magenheimer BS; Hempson SJ; Grantham JJ; Calvet JP
J Biol Chem; 2004 Sep; 279(39):40419-30. PubMed ID: 15263001
[TBL] [Abstract][Full Text] [Related]
56. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
Zhao CY; Greenstein JL; Winslow RL
J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
[TBL] [Abstract][Full Text] [Related]
57. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
[TBL] [Abstract][Full Text] [Related]
58. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.
Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245
[TBL] [Abstract][Full Text] [Related]
59. The PDE1-encoded low-affinity phosphodiesterase in the yeast Saccharomyces cerevisiae has a specific function in controlling agonist-induced cAMP signaling.
Ma P; Wera S; Van Dijck P; Thevelein JM
Mol Biol Cell; 1999 Jan; 10(1):91-104. PubMed ID: 9880329
[TBL] [Abstract][Full Text] [Related]
60. A cAMP and CREB-mediated feed-forward mechanism regulates GSK3β in polycystic kidney disease.
Kakade VR; Tao S; Rajagopal M; Zhou X; Li X; Yu AS; Calvet JP; Pandey P; Rao R
J Mol Cell Biol; 2016 Dec; 8(6):464-476. PubMed ID: 27190311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
